7.62
price up icon1.06%   0.08
after-market Handel nachbörslich: 7.69 0.07 +0.92%
loading
Schlusskurs vom Vortag:
$7.54
Offen:
$7.63
24-Stunden-Volumen:
92,956
Relative Volume:
0.02
Marktkapitalisierung:
$62.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.42M
KGV:
-1.3604
EPS:
-5.6013
Netto-Cashflow:
$-7.45M
1W Leistung:
+5.54%
1M Leistung:
-18.76%
6M Leistung:
-36.02%
1J Leistung:
-60.44%
1-Tages-Spanne:
Value
$7.31
$7.68
1-Wochen-Bereich:
Value
$7.18
$8.60
52-Wochen-Spanne:
Value
$1.80
$22.57

Cervomed Inc Stock (CRVO) Company Profile

Name
Firmenname
Cervomed Inc
Name
Telefon
(617) 744-4400
Name
Adresse
20 PARK PLAZA, BOSTON
Name
Mitarbeiter
15
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
CRVO's Discussions on Twitter

Vergleichen Sie CRVO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CRVO
Cervomed Inc
7.62 62.83M 0 -6.42M -7.45M -5.6013
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Cervomed Inc Stock (CRVO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-13 Hochstufung Chardan Capital Markets Neutral → Buy
2024-12-17 Herabstufung H.C. Wainwright Buy → Neutral
2024-12-11 Herabstufung Chardan Capital Markets Buy → Neutral
2024-12-11 Herabstufung Morgan Stanley Overweight → Underweight
2024-12-10 Herabstufung D. Boral Capital Buy → Hold
2024-12-06 Eingeleitet ROTH MKM Buy
2024-12-05 Eingeleitet H.C. Wainwright Buy
2024-09-18 Eingeleitet Chardan Capital Markets Buy
2024-07-26 Eingeleitet Morgan Stanley Overweight
2024-02-15 Eingeleitet Canaccord Genuity Buy
2020-11-17 Herabstufung H.C. Wainwright Buy → Neutral
2018-03-21 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Cervomed Inc Aktie (CRVO) Neueste Nachrichten

pulisher
Jun 05, 2025

BNP Paribas Financial Markets Purchases New Position in CervoMed Inc. (NASDAQ:CRVO) - Defense World

Jun 05, 2025
pulisher
Jun 01, 2025

Reviewing CervoMed (CRVO) and Its Peers - Defense World

Jun 01, 2025
pulisher
May 21, 2025

CervoMed Inc. (NASDAQ:CRVO) Given Average Rating of “Moderate Buy” by Analysts - Defense World

May 21, 2025
pulisher
May 19, 2025

CervoMed Releases New Business and Financial Information - TipRanks

May 19, 2025
pulisher
May 19, 2025

Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews

May 19, 2025
pulisher
May 18, 2025

Chardan Capital Raises Earnings Estimates for CervoMed - Defense World

May 18, 2025
pulisher
May 16, 2025

Roth Capital Brokers Reduce Earnings Estimates for CervoMed - Defense World

May 16, 2025
pulisher
May 16, 2025

Brokers Set Expectations for CervoMed Q2 Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

Insider Buying: William Elder Acquires Additional Shares of Cerv - GuruFocus

May 15, 2025
pulisher
May 15, 2025

CervoMed (NASDAQ:CRVO) Earns “Buy” Rating from D. Boral Capital - Defense World

May 15, 2025
pulisher
May 15, 2025

CervoMed Inc. (CRVO) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 15, 2025
pulisher
May 14, 2025

CervoMed’s CFO Makes Bold Move with New Stock Purchase! - TipRanks

May 14, 2025
pulisher
May 14, 2025

CervoMed First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Chardan keeps CervoMed stock Buy rating, $15 target post-results - Investing.com Australia

May 14, 2025
pulisher
May 14, 2025

CervoMed (CRVO) Maintains Buy Rating with Stable Price Target | - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Chardan Adjusts Price Target on CervoMed to $15 From $14, Maintains Buy Rating - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

CervoMed (CRVO) Maintains Buy Rating with Stable Price Target | CRVO Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

CervoMed Announces $50M Sales Agreement with Leerink - TipRanks

May 13, 2025
pulisher
May 13, 2025

Chardan Capital Issues Positive Forecast for CervoMed (NASDAQ:CRVO) Stock Price - Defense World

May 13, 2025
pulisher
May 13, 2025

CervoMed Inc. Reports Q1 2025 Financial Results - TipRanks

May 13, 2025
pulisher
May 12, 2025

Chardan keeps CervoMed stock Buy rating, $15 target post-results By Investing.com - Investing.com South Africa

May 12, 2025
pulisher
May 12, 2025

CervoMed Inc (CRVO) Q1 2025 Earnings: Revenue Beats Estimates at $1.9M, Net Loss Reported - GuruFocus

May 12, 2025
pulisher
May 12, 2025

CervoMed (CRVO): Chardan Capital Raises Price Target | CRVO Stoc - GuruFocus

May 12, 2025
pulisher
May 12, 2025

CervoMed (CRVO): Chardan Capital Raises Price Target | CRVO Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Cervomed Co Enters Sales Agreement With Leerink Partners LLC - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

CervoMed (CRVO) Financial Position and Funding Outlook | CRVO St - GuruFocus

May 12, 2025
pulisher
May 12, 2025

CervoMed (CRVO) Exceeds Q1 Revenue Expectations Amid Promising T - GuruFocus

May 12, 2025
pulisher
May 12, 2025

CervoMed Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

SEC Form 10-Q filed by CervoMed Inc. - Quantisnow

May 12, 2025
pulisher
May 12, 2025

CervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire

May 12, 2025
pulisher
May 12, 2025

CervoMed Inc. Reports Positive Phase 2b Results for Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies and Plans Phase 3 Trial - Nasdaq

May 12, 2025
pulisher
May 11, 2025

CervoMed (CRVO) to Release Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 10, 2025

CervoMed Announces Executive Appointments and Changes - MSN

May 10, 2025
pulisher
May 10, 2025

Mariner LLC Invests $30,000 in CervoMed Inc. (NASDAQ:CRVO) - Defense World

May 10, 2025
pulisher
May 08, 2025

JPMorgan Chase & Co. Grows Position in CervoMed Inc. (NASDAQ:CRVO) - Defense World

May 08, 2025
pulisher
May 07, 2025

CervoMed to Participate in H.C. Wainwright 3rd Annual BioConnect Investor Conference - GlobeNewswire

May 07, 2025
pulisher
May 02, 2025

CRVO Shares Experience Surge in Value - knoxdaily.com

May 02, 2025
pulisher
Apr 30, 2025

Head to Head Comparison: CervoMed (NASDAQ:CRVO) versus Schrödinger (NASDAQ:SDGR) - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

Analysts Set CervoMed Inc. (NASDAQ:CRVO) Price Target at $27.50 - Defense World

Apr 29, 2025
pulisher
Apr 19, 2025

What Will CervoMed Inc (NASDAQ: CRVO) Be Like In 2025 - Stocksregister

Apr 19, 2025
pulisher
Apr 18, 2025

CervoMed Inc. Announces Executive Appointments and Officer Departure By Investing.com - Investing.com South Africa

Apr 18, 2025
pulisher
Apr 18, 2025

CervoMed Inc. Announces Executive Appointments and Officer Departure - Investing.com Australia

Apr 18, 2025
pulisher
Apr 15, 2025

CervoMed (CRVO) to Present Key Findings on Dementia Drug at Inte - GuruFocus

Apr 15, 2025

Finanzdaten der Cervomed Inc-Aktie (CRVO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):